Cost-Effectiveness of a Child and Parent Mindfulness-Based Training Versus Medication for Childhood ADHD.
Rachel T van der Meulen, Francisca J A van Steensel, Esther I de Bruin et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the cost-effectiveness of family mindfulness training ('MYmind') compared to medication for childhood ADHD in 88 children. At 10 months, MYmind was found to be less cost-effective than medication for inattention, with a 27% probability of being cost-effective, but showed higher quality-adjusted life years (QALYs) at increased costs. In a subgroup analysis excluding crossover participants, MYmind had an 81% chance of being cost-effective.
Key findings
- MYmind had a 27% probability of being cost-effective for inattention.
- MYmind showed higher QALY gains but at higher costs compared to medication.
- In a subgroup analysis, MYmind had an 81% chance of being cost-effective for both outcomes.
- Shorter-term analyses indicated even lower chances for mindfulness being cost-effective.
Why it matters
Understanding the cost-effectiveness of treatment options for childhood ADHD is crucial for clinicians to make informed decisions that balance clinical outcomes with economic implications, especially in resource-limited settings.